Axsome Therapeutics, Inc.AXSMNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-26.32%
↑ 70% vs avg
Percentile
P60
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
-88.45%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -26.32% | +62.8% |
| 2024 | -70.68% | +15.0% |
| 2023 | -83.15% | +76.3% |
| 2022 | -350.53% | - |
| 2021 | 0.00% | - |
| 2013 | 0.00% | - |